Learning and research

10 July 2023

Pulmonary Hypertension Group 2: Pathophysiology & pathogenesis; In adults

Presented at PVRI 2023 Drug Development and Discovery Symposium (DDDS) by Raymond Benza, Ichan school of medicine at Mount Sinai

Members Only

10 July 2023

Taking the plunge with actigraphy: USA & China (lessons learnt)

Presented at PVRI 2023 Drug Development and Discovery Symposium (DDDS) by Peter Fernandes, Bellerophon Therapeutics

Members Only

10 July 2023

FNIH Initiative To Further The Clinical Outcome Assessment (COA) Development Of DHT Endpoints

Presented at PVRI 2023 Drug Development and Discovery Symposium (DDDS) by Josh Fessel,National Centre for Advancing Translational Sciences, & Jessilyn Dunn, Duke University

Members Only

10 July 2023

FDA Center for Drug Evaluation & Research (CDER) Division of Cardiology & Nephrology (DCN)

Presented at PVRI 2023 Drug Development and Discovery Symposium (DDDS) by Christine Garnett, FDA

Members Only

10 July 2023

Putting the physician in the corner: the patient-centred trial

Presented at PVRI 2023 Drug Development and Discovery Symposium (DDDS) by Joanna Pepke-Zaba, University of Cambridge

Members Only

10 July 2023

What can Bayesian adaptive designs offer for trials in rare disease?

Presented at PVRI 2023 Drug Development and Discovery Symposium (DDDS) by Sofia Villar, University of Cambridge

Members Only

10 July 2023

Stratified & adaptive trial designs

Presented at PVRI 2023 Drug Development and Discovery Symposium (DDDS) by Michael Harhay, University of Pennsylvania

Members Only

10 July 2023

FIT-PH/UK Cohort study - deciphering the Rosetta Stone of digital endpoints

Presented at PVRI 2023 Drug Development and Discovery Symposium (DDDS) by Alex Rothman, University of Sheffield

Members Only

30 June 2023

The role of Tregs - iPVD Inflammation and Infection Virtual Symposium series

'The role of Tregs' is part of the Inflammation and Infection Virtual Symposium series by the iPVD, a global education programme that highlights top-notch research on inflammation and infectious PVD.

IDDI Workstream or Task Force Learning

29 June 2023

June 2023 PVRI Community Call with Ruisheng Wang, Bradley Maron, Rachel Walters, Lan Zhao & Chermaine Kwant

In this Community Call, we discussed:

Elevated Pulmonary Arterial Compliance Is Associated with Survival in Pulmonary Hypertension: Results from a Novel Network Medicine Analysis
SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension
The UPHILL study: A nutrition and lifestyle intervention to improve quality of life for patients with pulmonary arterial hypertension

PVRI Community Calls

Related content